Tapewire

NYSE · USD

NHI

NATIONAL HEALTH INVESTORS INC

Export transactions ↓
Tapewire entity
4125
SEC CIK
0000877860
Parsed reports
247

Last 12 months

Inside the activity.

2 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202620
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 22, 2017 Filed Feb 24, 2017 22:54 UTC
PASCOE KEVIN CARLTONEVP - Investments
GrantStock Options (Right to Buy) 2-22-19 exp 2-22-22 · Derivative 16,668 $74.78 Strike: $74.78 $1,246,433.04
Disclosure

SEC source: 0001127602-17-008281 · form4.xml · derivative · entry 4

PASCOE KEVIN CARLTON · CIK 0001630773 · EVP - Investments

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,668

Underlying: Common Stock · 16,668 shares

Expires 2022-02-22

Read SEC document
February 22, 2017 Filed Feb 24, 2017 22:54 UTC
PASCOE KEVIN CARLTONEVP - Investments
GrantStock Options (Right to Buy) 2-22-18 Exp 2-22-22 · Derivative 16,666 $74.78 Strike: $74.78 $1,246,283.48
Disclosure

SEC source: 0001127602-17-008281 · form4.xml · derivative · entry 3

PASCOE KEVIN CARLTON · CIK 0001630773 · EVP - Investments

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,666

Underlying: Common Stock · 16,666 shares

Expires 2022-02-22

Read SEC document
February 22, 2017 Filed Feb 24, 2017 22:54 UTC
PASCOE KEVIN CARLTONEVP - Investments
GrantStock Options (Right to Buy) - 2-22-17 exp 2-22-22 · Derivative 16,666 $74.78 Strike: $74.78 $1,246,283.48
Disclosure

SEC source: 0001127602-17-008281 · form4.xml · derivative · entry 2

PASCOE KEVIN CARLTON · CIK 0001630773 · EVP - Investments

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,666

Underlying: Common Stock · 16,666 shares

Expires 2022-02-22

Read SEC document
February 22, 2017 Filed Feb 24, 2017 22:49 UTC
Hopkins Roger RChief Accounting Officer
GrantStock Options (Right to Buy) 2-22-19 exp 2-22-22 · Derivative 16,668 $74.78 Strike: $74.78 $1,246,433.04
Disclosure

SEC source: 0001127602-17-008278 · form4.xml · derivative · entry 4

Hopkins Roger R · CIK 0001385479 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,668

Underlying: Common Stock · 16,668 shares

Expires 2022-02-22

Read SEC document
February 22, 2017 Filed Feb 24, 2017 22:49 UTC
Hopkins Roger RChief Accounting Officer
GrantStock Options (Right to Buy) 2-22-18 Exp 2-22-22 · Derivative 16,666 $74.78 Strike: $74.78 $1,246,283.48
Disclosure

SEC source: 0001127602-17-008278 · form4.xml · derivative · entry 3

Hopkins Roger R · CIK 0001385479 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,666

Underlying: Common Stock · 16,666 shares

Expires 2022-02-22

Read SEC document
February 22, 2017 Filed Feb 24, 2017 22:49 UTC
Hopkins Roger RChief Accounting Officer
GrantStock Options (Right to Buy) - 2-22-17 exp 2-22-22 · Derivative 16,666 $74.78 Strike: $74.78 $1,246,283.48
Disclosure

SEC source: 0001127602-17-008278 · form4.xml · derivative · entry 2

Hopkins Roger R · CIK 0001385479 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,666

Underlying: Common Stock · 16,666 shares

Expires 2022-02-22

Read SEC document
February 22, 2017 Filed Feb 24, 2017 22:52 UTC
Mendelsohn D. EricCEO and President
GrantStock Options (Right to Buy) 2-22-19 exp 2-22-22 · Derivative 33,334 $74.78 Strike: $74.78 $2,492,716.52
Disclosure

SEC source: 0001127602-17-008280 · form4.xml · derivative · entry 4

Mendelsohn D. Eric · CIK 0001410716 · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,334

Underlying: Common Stock · 33,334 shares

Expires 2022-02-22

Read SEC document
February 22, 2017 Filed Feb 24, 2017 22:52 UTC
Mendelsohn D. EricCEO and President
GrantStock Options (Right to Buy) 2-22-18 Exp 2-22-22 · Derivative 33,333 $74.78 Strike: $74.78 $2,492,641.74
Disclosure

SEC source: 0001127602-17-008280 · form4.xml · derivative · entry 3

Mendelsohn D. Eric · CIK 0001410716 · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,333

Underlying: Common Stock · 33,333 shares

Expires 2022-02-22

Read SEC document
February 22, 2017 Filed Feb 24, 2017 22:52 UTC
Mendelsohn D. EricCEO and President
GrantStock Options (Right to Buy) - 2-22-17 exp 2-22-22 · Derivative 33,333 $74.78 Strike: $74.78 $2,492,641.74
Disclosure

SEC source: 0001127602-17-008280 · form4.xml · derivative · entry 2

Mendelsohn D. Eric · CIK 0001410716 · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,333

Underlying: Common Stock · 33,333 shares

Expires 2022-02-22

Read SEC document
February 22, 2017 Filed Feb 24, 2017 22:46 UTC
Gaines Kristin SalleeChief Credit Officer
GrantStock Options (Right to Buy) 2-22-19 exp 2-22-22 · Derivative 16,668 $74.78 Strike: $74.78 $1,246,433.04
Disclosure

SEC source: 0001127602-17-008273 · form4.xml · derivative · entry 4

Gaines Kristin Sallee · CIK 0001455833 · Chief Credit Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,668

Underlying: Common Stock · 16,668 shares

Expires 2022-02-22

Read SEC document
February 22, 2017 Filed Feb 24, 2017 22:46 UTC
Gaines Kristin SalleeChief Credit Officer
GrantStock Options (Right to Buy) 2-22-18 Exp 2-22-22 · Derivative 16,666 $74.78 Strike: $74.78 $1,246,283.48
Disclosure

SEC source: 0001127602-17-008273 · form4.xml · derivative · entry 3

Gaines Kristin Sallee · CIK 0001455833 · Chief Credit Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,666

Underlying: Common Stock · 16,666 shares

Expires 2022-02-22

Read SEC document
February 22, 2017 Filed Feb 24, 2017 22:46 UTC
Gaines Kristin SalleeChief Credit Officer
GrantStock Options (Right to Buy) - 2-22-17 exp 2-22-22 · Derivative 16,666 $74.78 Strike: $74.78 $1,246,283.48
Disclosure

SEC source: 0001127602-17-008273 · form4.xml · derivative · entry 2

Gaines Kristin Sallee · CIK 0001455833 · Chief Credit Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,666

Underlying: Common Stock · 16,666 shares

Expires 2022-02-22

Read SEC document
February 22, 2017 Filed Feb 24, 2017 22:41 UTC GrantStock Option Grant - 2-22-17 · Derivative 20,000 $74.78 Strike: $74.78 $1,495,600.00
Disclosure

SEC source: 0001127602-17-008270 · form4.xml · derivative · entry 3

WEBB ROBERT T · CIK 0001014282 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2022-02-22

Read SEC document
February 22, 2017 Filed Feb 24, 2017 22:35 UTC GrantStock Option Grant - 2-22-17 · Derivative 20,000 $74.78 Strike: $74.78 $1,495,600.00
Disclosure

SEC source: 0001127602-17-008266 · form4.xml · derivative · entry 2

MCCABE ROBERT A JR · CIK 0001079428 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2022-02-22

Read SEC document
February 22, 2017 Filed Feb 24, 2017 22:28 UTC
Jobe James RDirector
GrantStock Option Grant - 2-22-17 · Derivative 20,000 $74.78 Strike: $74.78 $1,495,600.00
Disclosure

SEC source: 0001127602-17-008262 · form4.xml · derivative · entry 3

Jobe James R · CIK 0001362322 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2022-02-22

Read SEC document
February 22, 2017 Filed Feb 24, 2017 22:26 UTC GrantStock Option Grant - 2-22-17 · Derivative 20,000 $74.78 Strike: $74.78 $1,495,600.00
Disclosure

SEC source: 0001127602-17-008260 · form4.xml · derivative · entry 10

ADAMS W ANDREW · CIK 0001012853 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2022-02-22

Read SEC document
February 21, 2017 Filed Feb 21, 2017 23:38 UTC Tax withholdingCommon Stock 9,593 $74.31 $712,855.83
Disclosure

SEC source: 0001127602-17-007514 · form4.xml · nonDerivative · entry 2

ADAMS W ANDREW · CIK 0001012853 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,407

Read SEC document
February 17, 2017 Filed Feb 21, 2017 23:38 UTC Exercise / conversionStock Options (Right to Buy) · Derivative 15,000 $0.00 Strike: $47.52 $0.00
Disclosure

SEC source: 0001127602-17-007514 · form4.xml · derivative · entry 11

ADAMS W ANDREW · CIK 0001012853 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2017-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 17, 2017 Filed Feb 21, 2017 23:38 UTC Exercise / conversionCommon Stock 15,000 $47.52 $712,800.00
Disclosure

SEC source: 0001127602-17-007514 · form4.xml · nonDerivative · entry 1

ADAMS W ANDREW · CIK 0001012853 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.